International Eosinophil Society, Inc.

Bruce S. Bochner, MD is Professor Emeritus as of February 1, 2023, after serving as the Samuel M. Feinberg Professor of Medicine in the Division of Allergy and Immunology at the Northwestern University Feinberg School of Medicine.  After postdoctoral training in allergy and immunology at Johns Hopkins in the Division of Allergy and Clinical Immunology, he joined the faculty in 1988, was promoted to professor in 1999 and subsequently served as Division Director from 2003 to 2013 before accepting the professorship at Northwestern. His primary interests centered on the function and regulation of eosinophils and mast cells. He is an author on over 300 manuscripts, and has served in leadership roles for the International Eosinophil Society.

Dr. Sharon Grisaru-Tal trained in the MD-PhD physician scientist program at Tel Aviv University. She completed a PhD in Clinical Microbiology and Immunology under the supervision of Prof. Ariel Munitz. Her PhD focused on investigating the role of eosinophils in the tumor microenvironment. She is currently completing her studies to become a medical doctor.  

Dr. Allison Fryer has demonstrated that eosinophils are actively recruited to airway nerves where they change nerve architecture, neurotransmitter content and neurotransmitter release in allergic, infectious, and environmental models of asthma. Her research was foundational to the now, widely accepted, tenet that neuroimmune interactions contribute to chronic inflammatory diseases. Dr. Fryer’s research is published in over 115 peer reviewed papers and book chapters. She is a Fellow of the British Pharmacological Society. She served as an editor for the British Journal of Pharmacology and for the American Journal Respiratory and Critical Care Medicine. Dr. Fryer has trained 16 PhD students and 14 postdoctoral fellows, many of whom are now leaders in academia and industry. She is currently Associate Dean for Graduate Studies in the School of Medicine at Oregon Health & Science University.  A member of the International Eosinophil Society for many years, she has served on the steering committee since 2018, and led the scientific committee that planned the 2019 IES meeting in Portland.

Dr. Florence Roufosse is Professor of Medicine, Internist and Clinical Immunologist at CUB- Hôpital Erasme, Brussels, and is President of the International Eosinophil Society. She is in charge of a specialized consultation dedicated to diagnosing and treating eosinophil-related conditions, that is integrated in the European Reference Network: EuroBloodNet. She also manages patients with systemic auto-immune and auto-inflammatory conditions.

Besides these clinical activities, Dr. Roufosse leads translational research projects to improve understanding and treatment of lymphocytic variant hypereosinophilic syndrome (HES), and participates in international research efforts to better delineate disease course and treatment responses in patients with HES HES. She is involved in the design and conduct of international clinical trials evaluating efficacy of novel treatment options for HES and eosinophilic granulomatosis with polyangiitis (EGPA), as well as sub-studies that aim to identify biomarkers and/or disease variants predicting treatment responses.